Plain-English translation of NCT03463564 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 1 Diabetes Mellitus research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial compares two ways of managing type 1 diabetes: using an insulin pump (a small device that delivers insulin continuously under your skin) versus taking four by needle each day. Researchers want to see which method helps young adults who are moving from pediatric clinics to adult diabetes care achieve better blood sugar control, with fewer dangerous low blood sugar episodes and smoother overall glucose levels.
Moving from a children's clinic to adult care is a difficult time for young people with type 1 diabetes — blood sugar often gets harder to control during this transition. While both insulin pumps and daily injections are proven treatments, no one has studied which works better for patients going through this specific life change.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to either use an insulin pump with rapid-acting insulin or continue with four daily. You'll visit the adult diabetes clinic regularly so doctors can monitor your blood sugar control, measure your HbA1c levels, and track how well each method is working for you. The study will follow you over time as you adjust to adult care and help researchers understand which insulin delivery method works best during this important transition.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Italy